share_log

HCW Biologics Says it Gets FDA Clearance for Phase 1 Trial of Cancer Drug Candidate; Shares Rise Pre-Bell

HCW Biologics Says it Gets FDA Clearance for Phase 1 Trial of Cancer Drug Candidate; Shares Rise Pre-Bell

HCW 生物製劑表示,它獲得 FDA 批准癌症候選藥物的第一階段試驗; 股價上漲前鐘
MT Newswires ·  2022/01/24 07:56

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論